Georg Meisl, a research associate at Yusuf Hamied Department of Chemistry, University of Cambridge shares insight into new research that sheds light on just…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
In the 1980s, when Cindy Weinstein was a graduate student of English, developing her expertise in language and literature, her father Jerry, now deceased,…
Early-onset dementia — sometimes referred to as young-onset — has long been a puzzle for doctors, scientists, and researchers alike. Initial symptoms of the…
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
A study finds that people who struggle to hear over background noise had as much as a 91-percent higher risk of dementia. Thomas Littlejohns,…
Alzheimer’s is a complex disease, and studies that follow participants over extended periods of time can gather troves of data on the progression of…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
Whether it be coping with the cognitive, behavioral or psychological symptoms of dementia, adapting caregiver strategies throughout the different stages of the illness is…
Scientists in the field of Alzheimer’s have struggled to carry promising findings in mice studies into human trials, but primate researchers believe that animals…
With a strong family history of Alzheimer’s, Dewayne Nash had expected that he would start experiencing symptoms of the disease by the time he…
Cassava Sciences revealed positive clinical data from their simufilam trial, a potentially disease-modifying therapy for treating Alzheimer’s. Their preliminary study showed that simufilam significantly…
Nicotine, a natural product of various plants including the tobacco plant, is notorious for its addictive properties in tobacco products like cigarettes. But the…